All In Biotech

Free tool

FAERS Monitor: Advil Congestion Relief

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022565 or its brand name (Advil Congestion Relief, Ibuprofen, Phenylephrine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

998

Serious

15

2% of reports

Hospitalization

6

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product use in unapproved indication289
  • drug ineffective257
  • drug effective for unapproved indication255
  • drug effect incomplete91
  • therapeutic product effect incomplete67
  • therapeutic response unexpected49
  • drug ineffective for unapproved indication48
  • pre-existing condition improved45
  • somnolence42
  • product use issue28
  • drug effect less than expected24
  • feeling abnormal19
  • condition aggravated15
  • headache15
  • hypersensitivity14

Reports by year received

View as table
YearReports
2015218
2016131
201779
201823
201943
202011
2021456
202215
20237
20246
20254
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,161 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug effective for unapproved indicationSignal255185.1166.446,161
pre-existing condition improvedSignal45153.0114.96,599
drug effect incompleteSignal9152.943.54,581
drug effect less than expectedSignal2434.223.0740
product use in unapproved indicationSignal28924.622.36,590
therapeutic response unexpectedSignal4923.017.51,012
therapeutic product effect incompleteSignal6719.915.81,185
drug ineffective for unapproved indicationSignal4818.414.0776
somnolenceSignal424.43.3108
drug ineffectiveSignal2574.13.7642
product use issueSignal283.12.239
feeling abnormal191.71.15
hypersensitivity141.60.93
condition aggravated151.00.60
headache150.50.37

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.